JAMA October 28, 2026

Left Bundle-Branch Area Pacing vs Right Ventricular Pacing for Atrioventricular Block and Preserved Left Ventricular Function

Li X, et al.

Bottom Line

In patients with atrioventricular block and preserved ejection fraction requiring a high burden of ventricular pacing, left bundle-branch area pacing significantly reduced the 24-month composite risk of death, heart failure events, or upgrade to biventricular pacing compared to right ventricular pacing.

Key Findings

1. LBBAP significantly reduced the primary composite endpoint of all-cause death, heart failure events, or upgrade to biventricular pacing compared to RVP (2.4% vs 12.5%; absolute risk difference, -10.1% [95% CI, -16.8% to -3.4%]; P = .003).
2. The 24-month Kaplan-Meier estimated cumulative incidence of the primary endpoint was 5.0% for LBBAP vs 13.2% for RVP (hazard ratio, 0.37 [95% CI, 0.19 to 0.73]; P = .004).
3. The LBBAP group experienced significantly fewer heart failure events (3.4% vs 11.3%; absolute risk difference, -7.9% [95% CI, -13.0% to -2.8%]).
4. Acute procedural success rates were comparable between the LBBAP (97.9%) and RVP (99.6%) groups (P = .22), with left bundle-branch capture confirmed in 79.7% of LBBAP patients.
5. There were no significant between-group differences in all-cause mortality, biventricular pacing upgrade rates, device-related complications, or pacing-induced cardiomyopathy at 24 months.

Study Design

Design
RCT
Open-Label
Sample
499
Patients
Duration
24 mo
Median
Setting
Multicenter, China
Population Patients with atrioventricular block and preserved left ventricular ejection fraction (LVEF greater than or equal to 50%) with an anticipated ventricular pacing burden greater than 40%.
Intervention Left bundle-branch area pacing (LBBAP).
Comparator Right ventricular pacing (RVP).
Outcome A composite of all-cause death, heart failure events, or upgrade to biventricular pacing at 24 months.

Study Limitations

• The 24-month follow-up duration and the limited sample size precluded the ability to show statistically significant differences in individual components of the composite outcome, such as all-cause mortality.
• Given the open-label nature of the trial, there is a potential for diagnosis bias; unblinded clinicians observing RV pacing morphology on ECGs might have had a lower threshold for diagnosing and admitting patients for heart failure events.
• The results may not be generalizable to patients requiring pacing for sinus node dysfunction who have normal atrioventricular conduction.
• The findings might not fully apply to institutions or operators utilizing stylet-driven leads for LBBAP, as specialized equipment was likely used in this trial.

Clinical Significance

The LEAP-Block trial provides robust, randomized evidence that conduction system pacing, specifically left bundle-branch area pacing, is clinically superior to traditional right ventricular pacing in preserving long-term outcomes for patients with atrioventricular block and preserved ejection fraction who require a high pacing burden. It reinforces the adoption of physiologic pacing strategies to mitigate the adverse remodeling and clinical heart failure historically provoked by chronic right ventricular apical or septal pacing.

Historical Context

For decades, right ventricular pacing was the standard therapy for atrioventricular block, despite a known association with electrical dyssynchrony and pacing-induced cardiomyopathy in patients with high pacing burdens. Although His-bundle pacing emerged as an initial physiologic alternative, it was limited by high pacing thresholds and higher lead revision rates. Left bundle-branch area pacing (LBBAP) recently gained traction as a more stable and feasible conduction system pacing technique. Following the 2023 Heart Rhythm Society guidelines that elevated physiologic pacing to a Class IIb recommendation, the LEAP-Block trial is a landmark randomized study that validates these guidelines by demonstrating meaningful clinical superiority of LBBAP over right ventricular pacing.

Guided Discussion

High-yield insights from every perspective

Med Student
Medical Student

Why does right ventricular apical pacing increase the risk of heart failure in patients with atrioventricular block, and how does left bundle-branch area pacing mitigate this risk?

Key Response

Right ventricular pacing creates an artificial left bundle branch block pattern, causing electromechanical dyssynchrony. Over time, especially with a high pacing burden, this dyssynchrony can lead to adverse left ventricular remodeling, reduced ejection fraction, and pacing-induced cardiomyopathy. Left bundle-branch area pacing engages the native conduction system, preserving synchronous ventricular activation and preventing this pacing-induced cardiomyopathy.

Resident
Resident

When evaluating a patient with complete heart block and a preserved ejection fraction, what specific clinical factor makes them an ideal candidate for LBBAP over traditional RVP?

Key Response

The primary driver for choosing conduction system pacing over RVP in preserved EF is an anticipated high burden of ventricular pacing, typically greater than 20 percent. Patients with complete AV block will pace nearly 100 percent of the time, putting them at the highest risk for pacing-induced dyssynchrony and heart failure, making them ideal candidates for LBBAP to preserve ventricular function.

Fellow
Fellow

During an LBBAP procedure, what electrocardiographic and electrophysiologic criteria are utilized to confirm true capture of the left bundle branch rather than just deep left ventricular septal capture?

Key Response

Confirming true LBB capture involves assessing the paced QRS morphology which is typically a right bundle branch block pattern, measuring the stimulus-to-LV activation time via V6 R-wave peak time usually under 75 to 80 ms, observing a transition in QRS morphology during threshold testing such as loss of LBB capture but retention of septal myocardial capture, and recording a left bundle branch potential. Distinguishing true conduction system capture from deep septal pacing is critical for optimal long-term outcomes.

Attending
Attending

Given the superiority of LBBAP over RVP in preventing the composite of death, heart failure events, or biventricular upgrade at 24 months, should LBBAP now be considered the default pacing strategy for all patients with AV block, or are there specific populations where RVP remains the safer choice?

Key Response

While LBBAP shows significant benefits in preventing pacing-induced cardiomyopathy, it is a more complex procedure with a steeper learning curve, longer fluoroscopy times, and potential for specific complications like septal perforation. In elderly, frail patients with limited life expectancy or those with intermittent AV block where pacing burden is expected to be low, the simplicity, shorter procedural time, and established long-term safety of RVP may still make it the preferred choice.

Scholarly Review

Critical appraisal through the lens of expert reviewers and guideline development

PhD
PhD

The trial utilizes a composite primary endpoint of death, heart failure events, or upgrade to biventricular pacing. How does the inclusion of a subjective endpoint like 'upgrade to biventricular pacing' alongside mortality threaten the internal validity of the study, particularly in an unblinded or single-blinded trial?

Key Response

Composite endpoints can be statistically driven by their least severe but most frequent component. 'Upgrade to biventricular pacing' is a clinical decision that can be highly subjective and influenced by physician bias, especially if the treating electrophysiologist is aware of the patient's assigned arm. This lack of blinding can lead to a differential threshold for intervention, artificially inflating the apparent benefit of LBBAP if physicians are quicker to upgrade symptomatic RVP patients.

Journal Editor
Journal Editor

What are the primary methodological concerns regarding the operator learning curve and procedural standardization in a multi-center trial evaluating LBBAP, and how should a reviewer assess the generalizability of these findings to community practice?

Key Response

LBBAP is a relatively novel and technically demanding procedure. A critical reviewer would flag whether the trial restricted operators to those with high procedural volumes which maximizes safety and efficacy but reduces generalizability to average community electrophysiologists, or included novice operators which risks confounding the results with learning curve-related complications such as lead dislodgment or septal perforation. Standardization of definitions for true LBB capture across sites is also a major threat to validity if loosely enforced.

Guideline Committee
Guideline Committee

Based on the findings of this trial demonstrating the superiority of LBBAP over RVP in AV block with preserved EF, how should the current pacing guidelines be updated regarding the Class of recommendation for conduction system pacing in this cohort?

Key Response

Current 2021 ESC guidelines give a Class IIa recommendation for conduction system pacing or biventricular pacing in patients with AV block and preserved LVEF if greater than 20 percent ventricular pacing is expected. The robust randomized data from this trial, showing clear reduction in clinical events such as heart failure and upgrades, provides strong evidence to potentially elevate LBBAP to a Class I recommendation as a first-line therapy over RVP for patients with AV block and anticipated high pacing burden, explicitly prioritizing it due to physiological superiority.

Clinical Landscape

Noteworthy Related Trials

2009

PACE Trial

n = 177 · NEJM

Tested

Biventricular pacing

Population

Patients with bradycardia and normal LV ejection fraction

Comparator

Right ventricular pacing

Endpoint

LV ejection fraction and LV end-systolic volume at 12 months

Key result: Biventricular pacing prevented the reduction in LV ejection fraction and increase in LV volume seen with right ventricular apical pacing.
2013

BLOCK HF Trial

n = 691 · NEJM

Tested

Biventricular pacing

Population

Patients with AV block and mildly reduced left ventricular ejection fraction

Comparator

Right ventricular pacing

Endpoint

Composite of mortality, urgent care for heart failure, or a 15% increase in LV volume

Key result: Biventricular pacing significantly reduced the primary composite outcome compared to right ventricular pacing.
2019

His-SYNC Trial

n = 41 · JACC

Tested

His-bundle pacing

Population

Patients with indications for cardiac resynchronization therapy

Comparator

Biventricular pacing

Endpoint

Improvement in QRS duration and echocardiographic response at 6 months

Key result: His-bundle pacing showed a trend toward better QRS narrowing and comparable echocardiographic response to biventricular pacing, despite a high crossover rate.

Tailored to your role

Want this tailored to you?

Add your specialty or training stage to get role-specific takeaways and more questions.

Personalize this analysis
↑